Find a Study
MedX focuses on metabolic, endocrine, and cardiometabolic conditions — where the science is moving fastest and where Houston's patients have been most underrepresented. Browse our current focus areas below.
Our Focus Areas
Every trial we run is either actively recruiting, in activation, or in our near-term pipeline. Click a condition to learn what's available and whether you may qualify.
Metabolic
Research into next-generation glycemic control — including novel insulin analogs, GLP-1 receptor agonists, and combination therapies for patients managing or newly diagnosed with Type 2 diabetes.
See If You Qualify →Metabolic
Sponsor-funded trials on breakthrough weight-management interventions — incretin mimetics, combination therapies, and cardiometabolic risk reduction studies. Some of the most rapidly advancing research in medicine today.
See If You Qualify →Hepatology
Metabolic-associated steatohepatitis and fatty liver disease research — a therapeutic area where the FDA has only recently approved its first treatment, and where many patients don't yet know clinical options exist.
See If You Qualify →Endocrine
Studies focused on hypothyroidism, hyperthyroidism, and thyroid autoimmunity — including trials of new formulations, dosing strategies, and long-term outcome research for patients already on replacement therapy.
See If You Qualify →Cardiometabolic
Research on LDL-lowering therapies, PCSK9 inhibitors, and emerging lipid-modifying approaches. If your cholesterol isn't responding to standard treatments, new investigational options may be available through a trial.
See If You Qualify →Endocrine
Polycystic ovary syndrome research — a chronically underinvestigated condition where new metabolic and hormonal interventions are finally reaching clinical trials. If you've been told there's nothing new to try, this page is for you.
See If You Qualify →Something Else?
Our current focus is metabolic and endocrine health — but we're continuously expanding, and we maintain a warm list of patients interested in future trials across many other conditions.